The MarketWatch News Department was not involved in the creation of this content.
Sep 25, 2020 (Market Insight Reports) —
Selbyville, Delaware According to the research report titled ‘Asia Pacific Apheresis Equipment Market Share By Product, Application,A Procedure, Technology, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report LLC, Asia-Pacific apheresis equipment market is expected to cross USD 1.3 billion by the year 2026.
Increased pervasiveness of blood disorders has impelled the demand for apheresis equipment, which in turn is a major factor driving the market growth in Asia-Pacific. For those uninitiated, apheresis is a blood processing technique which is used for treating clinical conditions such as neurologic, neoplastic and hematologic disorders. Apheresis equipment can also help in lowering the number of pathogens in plasma and in platelets, thereby stimulating the industry outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683090/?utm_source=Marketwatch.com&utm_medium=AN
Focus towards development of healthcare infrastructure is further aiding the market expansion. Additionally, introduction of blood safety strategies by public entities towards providing adequate and safe blood supply is facilitating the business scenario in Asia-Pacific.
Rising number of accredited and licensed blood banks are also augmenting the industry remuneration. However, high capital investments associated with apheresis techniques may act as a restraining factor to the overall market growth.
As per product type, the report claims that apheresis machine segment accounted for substantial revenue share in the year 2019 and is expected to grow with a CAGR of 15% through 2026. These machines are used to obtain blood from donors and subsequently separate it into various blood components including red blood cells, white blood cells, platelets and plasma. Ongoing advancements in apheresis machines is thus fueling the segmental share.
Elaborating on the application spectrum, Asia-Pacific apheresis equipment market from hematology segment generated revenues worth USD 225 million in the year 2019. HAU (Hematology apheresis unit) is widely used to analyze blood and marrow components. In addition, growing demand for blood and blood products is favoring the overall market outlook in APAC.
Moving on to procedure type, the report claims that leukapheresis segment is predicted to reach a valuation of USD 110 million by the year 2026. This procedure helps in removing additional leukocytes from the blood. Rising prevalence of febrile neutropenia is positively influencing the growth of the segment.
In terms of technology, membrane filtration segment was worth USD 405.5 million in the year 2019. Rising adoption of membrane filtration technology owing to its high precision and cost effective nature is favoring the market scenario in Asia-Pacific.
Regionally, India apheresis equipment market is anticipated to showcase a y-o-y growth rate of 12.8% between 2020 and 2026. Technological advancements and increasing investments towards healthcare sector are augmenting the regional demand for apheresis equipment.
Therakos Inc., Terumo BCT Inc., Kawasumi Laboratories Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Kaneka Corporation, B. Braun Melsungen AG, and Asahi Kasei Corporation are the key participants in Asia-Pacific apheresis equipment market.
Question & Answer: Asia-Pacific Apheresis Equipment Market
Question 1: What factors are fueling the demand for apheresis equipment in Asia-Pacific?
Answer: Increased pervasiveness of blood disorders and focus towards development of healthcare infrastructure have impelled the demand for apheresis equipment, which in turn is a major factor driving the market growth in Asia-Pacific.
Question 2: Why is membrane filtration technology gaining worldwide recognition?
Answer: Rising adoption of membrane filtration technology owing to its high precision and cost effective nature is favoring the market scenario in Asia-Pacific.
Question 3: Which companies define the competitive terrain of Asia-Pacific apheresis equipment industry?
Answer: Therakos Inc., Terumo BCT Inc., Kawasumi Laboratories Inc., Haemonetics Corporation, Fresenius SE & Co. KGaA, Kaneka Corporation, B. Braun Melsungen AG, and Asahi Kasei Corporation are the key participants in Asia-Pacific apheresis equipment market.
Complete Report At: https://www.marketstudyreport.com/reports/asia-pacific-apheresis-equipment-market-statistics?utm_source=Marketwatch.com&utm_medium=AN
About Us:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: [email protected]
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on [email protected]
COMTEX_371837388/2599/2020-09-25T01:04:45
Is there a problem with this press release? Contact the source provider Comtex at [email protected]. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.